Litigation Details for JANSSEN PRODUCTS, L.P. v. EVENUS PHARMACEUTICALS LABORATORIES INC. (D.N.J. 2020)
✉ Email this page to a colleague
JANSSEN PRODUCTS, L.P. v. EVENUS PHARMACEUTICALS LABORATORIES INC. (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-07-23 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | Referred To | ||
| Patents | 8,895,557 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in JANSSEN PRODUCTS, L.P. v. EVENUS PHARMACEUTICALS LABORATORIES INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for JANSSEN PRODUCTS, L.P. v. EVENUS PHARMACEUTICALS LABORATORIES INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-04-07 | 222 | Opinion | 7644 States Patent Nos. 8,895,557 (“the ‘557 Patent”) and 7,420,051 (“the ‘051 Patent,” together, the…filing this patent infringement suit. In accordance with this district’s Local Patent Rules, the parties…Court construes a single disputed claim term in a patent that is directed to trabectedin anti-tumor drug…PROCEDURAL HISTORY Plaintiffs bring this patent infringement suit against Defendants 1 for infringement…the “patents in suit”) based on the filing of two Abbreviated New Drug Applications (“ANDAs”) with | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
